ArticleCancer medicine2025

Real-World Data on Inotuzumab Ozogamicin for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia: A GRELAL-Chile Study.

Marcela Espinoza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.